The End of EQRx

EQRx, the company we've talked about on this podcast before launched in early 2020 with a plan to make new treatments specifically for cancer more cheaply than had been done in the past. The deal basically is EQRx being liquidated into another company that happens to have ties to Third Rock Ventures. It's a really funny time for investors because a lot of investors are actually still sitting there on quite a bit of cash.